FABP5 and neoplasm: Similarly, targeting FABP5, a lipid chaperone upregulated by tumor‐derived IL‐10, decreases lipid storage in TAMs and restores β‐oxidation rates, countering chemotherapy resistance in hepatocellular carcinoma [64].